Let us know your thoughts. Send us a Text Message.

Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedIn.

Episode Title:- 🇨🇭Commercialise Neurotechnology🇨🇭

In this #HTNeurotechSeries episode of Heads Talk, I am joined by Patricia Bradley, Global Chief Commercial Officer of MindMaze and this was a conversation about ‘go to market’ and the unique complexities for a Neurotech startup as opposed to other technology startups in the, for example, financial space.  

Definitely one for those of you with a Neurotech startup, ready to scale up enterprise. 

A bit about MindMaze: It is a Neurotechnology company that famously became the 1st Swiss unicorn, when in 2016 it raised $100 million Dollars in Series A1 funding. 

Topics Covered:

• Neurotech Investors
• Ecosystem (Lack of)
• Commercialised Components to Clinical Trials
• Reimbursement Issues
• The Pitch
• Collaboration with Pharmaceutical Companies

So download⏳grab a cup of Bird & Blend Tea Co - Enchanted Nania Tea ☕️& have a listen🛋

Series Sponsored by - PrivCap Resource Group

Series Partnered with Foresight Institute

Next week's guest announced on LinkedIn every Monday. Follow me to see.

ABOUT THE HOST
HeadsTalk #HeadsTalkPodcast #AFlyOnTheBoardroomWall #HTNeurotechSeries

MindMaze Testimonials: https://mindmaze.com/testimonials/

Support the show

Follow, Support, Contact Heads Talk® - A Fly On The Boardroom Wall

• LinkedIn
• Website
• Twitter
• Email at [email protected]